Contact PI/Project LeaderGALLAGHER, DYMPNA Other PIs
Awardee OrganizationCOLUMBIA UNIVERSITY HEALTH SCIENCES
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
The New York Obesity Nutrition Research Center (NYNORC) has as its primary aim to convene and support -
by its Core Services, Pilot & Feasibility and Enrichment programs - funded investigators at Columbia University
and the Albert Einstein College of Medicine studying obesity. The themes for this Center include: the etiology,
pathophysiology and complications of obesity; treatment strategies; the physiology of weight regulation and
nutrient use; development of new tools and strategies for the study of nutrition and obesity; and the training and
development of scientists to study nutrition and obesity. A particular strength of the NYNORC, by design, is an
explicit commitment to the promotion of multidisciplinary research that integrates basic observations relating to
nutritional, metabolic and behavioral biology, with the application of these insights to clinical approaches to the
prevention and treatment of obesity. The size and breadth of our base has provided a strong basis for
collaborations and productivity. During the current cycle, the research base has grown from 109 to 115 funded
members. Currently, NYNORC members were PIs on 206 obesity-related grants totaling $60M/annum in
direct costs: 166 grants from NIH totaling $48M/annum ($13M NIDDK) and 40 foundations and
pharmaceutical entities supported obesity-related grants totaling $11M/annum. NYNORC Members are
PIs of 12 NIH training grants, 14 P30 and P50 program projects, the CTSA at Columbia, and mentors of 10 K
series and 4 F31 graduate awards. These efforts are supported by our three Biomedical Research Cores:
Human Phenotyping, Animal Phenotyping and Molecular Biology/Molecular Genetics. Since the last submission,
the Cores have provided ~40,000 services to 115 members, including ~8464 services provided by the Human
Phenotyping Core, 10,231 services from the Animal Phenotyping Core and >20,000 service requests by the
Molecular Genetics/Molecular Biology Core. The research base is also supported by a highly successful Pilot
& Feasibility Program – subsidized by the sponsoring institutions - that awarded $1.2M to 13
investigators since the last submission and 3 new awards to begin this summer. In addition, through the
Naomi Berrie Diabetes Center programs in Frontiers in Diabetes Research, the Russell Berrie Initiative in the
Neurobiology of Obesity and the recently inaugurated Preliminary Translational Research Program, the
NYNORC has access to an additional ~$2M in annual funds to support innovative studies related to the
pathogenesis and treatment of obesity. The NYNORC is a dynamic enterprise that has strong institutional
support permitting it to evolve and thrive as it fosters novel and collaborative science in the study of obesity. This
evolution is apparent in the role of members of the NYNORC in creating intellectual and physical resources for
addressing basic and translational research approaches to COVID-19 epidemic.
Public Health Relevance Statement
PROJECT NARRATIVE
The NYNORC, the oldest NIH obesity research center, operates in support of $60M per year
of peer-reviewed obesity-related research. Through closely integrated, outstanding core
facilities, pilot projects, enrichment and clinical activities, the center has made major
contributions to basic understanding and applied approaches to the problem of obesity. Our
goal remains to expand the knowledge base relating to the causes, complications and
treatments of obesity.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AchievementAddressAdvisory CommitteesAllyAnimalsAreaAwardBackBasic ScienceBehaviorBehavioralBile AcidsBiologyBiomedical ResearchBody CompositionCOVID-19 pandemicCell TherapyCenter Core GrantsClinicalClinical InvestigatorCollaborationsCommunitiesCore FacilityCreativenessDefense MechanismsDevelopmentDiabetes MellitusDirect CostsDiseaseEatingElementsEnvironmentEtiologyEvolutionFatty LiverFood Intake RegulationFosteringFoundationsFunctional disorderFundingFunding AgencyGenesGoalsGrantHumanIndividualInstitutionInterdisciplinary StudyInvestigationLaboratoriesManuscriptsMediationMedical centerMedicineMentorsMetabolicMolecular BiologyMolecular GeneticsMonitorNational Institute of Diabetes and Digestive and Kidney DiseasesNeurobiologyNeuronsNeurosciencesNew YorkNewborn InfantNutrientNutritionalNutritional StudyObesityPathogenesisPathologyPatientsPeer ReviewPharmacologic SubstancePhenotypePhysiologicalPhysiologyPilot ProjectsPreventionPrevention approachPrevention strategyProductivityPublishingRecording of previous eventsRegulationResearchResearch PersonnelResearch Project GrantsResourcesRoleScienceScientistSeriesServicesSpecialized CenterTechniquesTrainingTranslational ResearchUnited States National Institutes of HealthUniversitiesWeightWeight Gainbaseclinical carecollegecomorbiditydesigndosagefrontierinnovationinsightinstrumentinterdisciplinary collaborationinterestinvestigator trainingknowledge basemembernext generationnovelnutritionobesity developmentobesity in childrenobesity treatmentpractical applicationpreferenceprogramsresearch clinical testingrisk variantskillsstem cellssugartooltranslational research programtreatment strategy
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
621889815
UEI
QHF5ZZ114M72
Project Start Date
01-December-1996
Project End Date
14-March-2025
Budget Start Date
01-April-2024
Budget End Date
14-March-2025
Project Funding Information for 2024
Total Funding
$1,221,081
Direct Costs
$820,033
Indirect Costs
$401,048
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Diabetes and Digestive and Kidney Diseases
$1,221,081
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P30DK026687-44
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P30DK026687-44
Patents
No Patents information available for 5P30DK026687-44
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P30DK026687-44
Clinical Studies
No Clinical Studies information available for 5P30DK026687-44
News and More
Related News Releases
No news release information available for 5P30DK026687-44
History
No Historical information available for 5P30DK026687-44
Similar Projects
No Similar Projects information available for 5P30DK026687-44